- ASGO 2nd International Workshop on Gynecologic Oncology
-
Matsumura , Mandai M, Konishi I
- KMID: 2288554
- J Gynecol Oncol.
- 2013 Jan;24(1):3-6.
- doi: 10.3802/jgo.2013.24.1.3
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics
-
Konishi I, Abiko K, Hayashi T, Yamanoi K, Murakami R, Yamaguchi K, Hamanishi J, Baba T, Matsumura N, Mandai M, Kyoto Study Group for Ovarian Cancer Research
- KMID: 2537916
- J Gynecol Oncol.
- 2022 Sep;33(5):e83.
- doi: 10.3802/jgo.2022.33.e83
Epithelial ovarian cancer remains the lethal gynecological malignancy in women. The representative histotype is high-grade serous carcinoma (HGSC), and most patients with HGSC present at advanced stages with peritoneal dissemination.... -
- CITED
-
- Close
- SHARE
-
- Close
- The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients
-
So M, Miyamoto T, Murakami R, Abiko K, Hamanishi , Baba T, Mandai M
- KMID: 2458903
- J Gynecol Oncol.
- 2019 Nov;30(6):e100.
- doi: 10.3802/jgo.2019.30.e100
OBJECTIVE: In patients with recurrent ovarian cancer (ROC) in whom surgery is likely to render them disease-free, it is unclear whether secondary cytoreductive surgery (SCS) combined with chemotherapy is superior... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
-
Ueda A, Watari H, Mandai M, Fukuhara S, Sugitani Y, Ogino K, Kamijima S, Enomoto T
- KMID: 2537969
- J Gynecol Oncol.
- 2022 Nov;33(6):e78.
- doi: 10.3802/jgo.2022.33.e78
Objective To assess the incidence of bevacizumab-associated gastrointestinal (GI) perforation during first-line treatment of patients with ovarian, fallopian tube, or peritoneal cancer receiving neoadjuvant chemotherapy (NAC) in Japanese real-world clinical practice. Methods A... -
- CITED
-
- Close
- SHARE
-
- Close
- Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer
-
Sakae C, Yamaguchi , Matsumura , Nakai H, Yoshioka Y, Kondoh E, Hamanishi , Abiko K, Koshiyama , Baba T, Kido A, Mandai M, Konishi I
- KMID: 2374259
- J Gynecol Oncol.
- 2016 Nov;27(6):e57.
- doi: 10.3802/jgo.2016.27.e57
OBJECTIVE: To identify suitable diagnostic tools and evaluate the efficacy of sentinel lymph node (SLN) biopsy for inguinal lymph node metastasis in vulvar cancer. METHODS: Data from 41 patients with vulvar... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
-
Kobayashi Y, Masuda K, Hiraswa A, Takehara K, Tsuda H, Watanabe Y, Oda K, Nagase S, Mandai M, Okamoto A, Yaegashi N, Mikami M, Enomoto T, Aoki D, Katabuchi H, Working Group on Clinical Practice for Cancer Genomic Medicine and HBOC, Japan Society of Gynecologic Oncology
- KMID: 2537910
- J Gynecol Oncol.
- 2022 Sep;33(5):e61.
- doi: 10.3802/jgo.2022.33.e61
Objective The practices pertaining to hereditary breast and ovarian cancer (HBOC) in Japan have been rapidly changing owing to the clinical development of poly(ADP-ribose) polymerase inhibitors, the increasing availability of companion... -
- CITED
-
- Close
- SHARE
-
- Close
- Quality indicators for cervical cancer care in Japan
-
Watanabe T, Mikami M, Katabuchi , Kato S, Kaneuchi M, Takahashi , Nakai H, Nagase S, Niikura H, Mandai M, Hirashima , Yanai H, Yamagami W, Kamitani S, Higashi T
- KMID: 2431230
- J Gynecol Oncol.
- 2018 Nov;29(6):e83.
- doi: 10.3802/jgo.2018.29.e83
OBJECTIVE: We aimed to propose a set of quality indicators (QIs) based on the clinical guidelines for cervical cancer treatment published by The Japan Society of Gynecologic Oncology, and to... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study
-
Machida H, Matsuo K, Oba K, Aoki D, Enomoto T, Okamoto A, Katabuchi H, Nagase S, Mandai M, Yaegashi N, Yamagami W, Mikami M
- KMID: 2536009
- J Gynecol Oncol.
- 2022 Jan;33(1):e3.
- doi: 10.3802/jgo.2022.33.e3
Objective Associations between hospital treatment volume and survival outcomes for women with 3 types of gynecologic malignancies, and the trends and contributing factors for high-volume centers were examined. Methods The Japan Society of... -
- CITED
-
- Close
- SHARE
-
- Close
- Asian Society of Gynecologic Oncology International Workshop 2018
-
Kong TW, Ryu HS, Kim SC, Enomoto T, Li J, Kim KH, Shim SH, Wang PH, Therasakvichya S, Kobayashi , Lee M, Shi T, Lee SW, Mikami M, Nagase S, Lim MC, Wang J, Wilailak S, Kim SW, Hong SH, Tan DS, Mandai M, Chang SJ, Huang RY, Ushijima K, Lee JY, Chen X, Ochiai K, Lee TS, Yang B, Kalam F, Lv Q, Ahmad MF, Yaznil MR, Modi KB, Manopunya , Jeong DH, Lertkhachonsuk Aa, Chung HH, Watari H, Jeon S
- KMID: 2457142
- J Gynecol Oncol.
- 2019 Mar;30(2):e39.
- doi: 10.3802/jgo.2019.30.e39
The Asian Society of Gynecologic Oncology International Workshop 2018 on gynecologic oncology was held in the Ajou University Hospital, Suwon, Korea on the 24th to 25th August 2018. The workshop... -
- CITED
-
- Close
- SHARE
-
- Close
